Clinical Trials Directory

Trials / Unknown

UnknownNCT01849471

Socioeconomic Aspects Before and After Radiation Therapy in Patient With Prostate Cancer

Evaluation of Socioeconomic Aspects Before and After Primary Radiation Therapy (Percutaneous or Interstitial or Combined Percutaneous and Interstitial) in Patients With Prostate Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial is an interrogation of patients with prostate cancer to evaluate socioeconomic effects of radiotherapy. Patients with percutaneous or interstitial or combined percutaneous and interstitial radiotherapy are included. Beside medical effects and adverse events, it's prospectively needed to extensively inform patients about socioeconomic aspects associated with radiotherapy. The interrogation comprises to collect possible costs and expenditures during and after therapy. Aspects especially concerning post therapy period include additional consultations, individual applied alternative medical care, need for additional medical aids (salves, medicine, bandages) and changes in professional and social situation. It's figured out in what extend costs are absorbed by health insurance coverage. In Germany there is no appropriate trial with respective patient population and respective therapy. Primary endpoint is the evaluation of therapy concerning and follow-up costs as well as changes in social and professional situation. Secondary endpoints are quality of life, adverse events of therapy and the correlation of quality of life, adverse events and economic aspects for the patient and the health insurance coverage.

Conditions

Interventions

TypeNameDescription
OTHERquestionnairespatients receive questionnaires regarding socioeconomic aspects before, during and after therapy

Timeline

Start date
2013-04-01
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2013-05-08
Last updated
2016-08-01

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01849471. Inclusion in this directory is not an endorsement.